Catalyst Wire Dossier Catalyst Wire Dossier

Tapentadol ER Tamper-Resistant Formulation (TRF) Tablet

tapentadol · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tapentadol ER Tamper-Resistant Formulation (TRF) Tablet, covering 2013-11-01 to 2013-11-01. Get the full timeline:

Most recent: Clinical Trial Update: A Pivotal Study to Evaluate the Bio-equivalence of the Tapentadol Extended-Release (ER) Tamper-resistant Formulation (TRF) Tablet to the Current Tapentadol ER Prolonged-release 2 (PR2) Tablet [Phase 1]

See pricing